SPERMTECH — A NEW ERA IN SEMINAL ANALYTICS
SPERMTECH is a Spanish company specialized in diagnostic reproductive biotechnology in both veterinary and human reproduction.
SPERMTECH designs, produces and markets high-precision automatic seminal analysis systems for the evaluation of key sperm parameters: motility, morphology, concentration, acrosomal integrity, viability and DNA fragmentation. Cross-cutting presence in animal production, aquaculture, biomedical research and assisted human reproduction.
Testhim in partnership with Logixx Fertility is all about filling the gap in male fertility awareness. Our mission is to empower men by providing support, education and comprehensive diagnostics so that they can understand their fertility and treatment options. Through a wealth of online content and a free online questionnaire , men can quickly discover how their lifestyle and health history may be affecting their fertility. With instant recommendations for diet and lifestyle changes as well as advanced fertility tests men can take control of their fertility health. Further support through testhim Andrology Clinical Services, in collaboration with LogixX Fertility and Fitzrovia Hospital, offers a streamlined, reliable, and high-quality diagnostic pathway for male fertility. Our services span essential, baseline, and advanced andrology investigations, alongside pathology testing, to support accurate and timely diagnosis ensuring clinicians are supported and men are fully informed about their fertility health.
Miltenyi Biotec is a global leader in innovating technologies and services for patient-specific cell and gene therapies, turning scientific discoveries into practical treatments for personalized medicine. Having pioneered a groundbreaking method of cell separation, Miltenyi Biotec continues to set industry standards today. With over 35 years of expertise, it supports customers in biomedical discoveries, translating them into clinical applications to enable access to new therapies for patients. Miltenyi Biotec focuses on providing integrated, advanced solutions to address complex challenges in the treatment of cancers, autoimmune diseases, and inherited disorders. Through its Miltenyi Bioindustry division, it provides expert guidance to therapy developers, helping them efficiently and cost-effectively navigate the path from process development to commercialization. Miltenyi Biotec is headquartered in Bergisch Gladbach and has a global team of over 5,000 employees across 27 countries.
Cryolab is a leading manufacturer and distributor of cryogenic IVF products within the human and animal disciplines, with decades of experience supporting fertility clinics and laboratories worldwide. At the Spermatology Exhibition, we showcase innovative solutions designed to improve sperm analysis, handling, and storage. Our Spermscope is a reusable cell analysis chamber designed for a comfort fit on a microscope offered in both 10 and 20 microns. Our advanced cryogenic storage vessels ensure reliable, secure long-term preservation with optimal temperature stability and safety. Cryolab combines engineering excellence with practical laboratory insight, providing dependable tools that streamline workflows and protect valuable samples across every stage of the reproductive process.
ExSeed Health is a pioneering MedTech company dedicated to advancing male reproductive health. We develop clinically validated medical devices and digital solutions that enable accurate assessment and improvement of sperm quality in both clinical and at-home settings. Our portfolio includes CASA Lite, an AI-powered semen analysis system for clinics, alongside an at-home sperm testing solution and a connected patient dashboard that enhances workflow efficiency and patient engagement. ExSeed Health delivers a comprehensive, evidence-based approach to male fertility, combining diagnostics, lifestyle intervention programmes, supplements, and an integrated HCP–patient management platform. Our mission is to improve male fertility outcomes while modernising care delivery across the fertility pathway.
As part of the organisation of this conference, the University of Birmingham is collecting income via registration fees and sponsorships on behalf of the Spermatology 2026 organising committee.
Accessibility Statement